RPS 14.3 — Safety Guide for Radiation Protection in Radiotherapy (2008)
1. Source documents
- Official PDF retained locally — ARPANSA, 2008 electronic edition with Annex L removed January 2015; retrieved 16 September 2026.
- Extracted text
- Provenance and SHA-256 metadata
2. Authority and jurisdiction
- Non-mandatory Australian safety guide supporting radiotherapy protection and implementation of the medical-exposure code.
- It is not Queensland legislation. A recommendation gains legal force only through a demonstrated adoption, licence/approval condition or other binding mechanism.
- Its former parent code, RPS 14, is withdrawn and superseded by RPS C-1 plus RPS C-5. ARPANSA continues to identify RPS 14.3 as interim best-practice support for RPS C-5 while the guide is revised; later binding instruments prevail.
3. Key takeaways
- Treats radiation therapy as a safety-critical multidisciplinary system spanning prescription, equipment, calibration, planning, delivery, QA, incident response and records.
- RPS 14.1, 14.2 and 14.3 remain supporting guides for diagnostic/interventional radiology, nuclear medicine and radiotherapy respectively; only 14.3 is directly centred on this practice.
- Distinguishes the responsibilities of the Responsible Person, radiation oncologist, radiation therapist, radiation oncology medical physicist, RSO, supplier and service personnel.
- Requires justification and optimisation for patient exposure, with accurate prescription, calibration, clinical dosimetry and independent checking.
- Emphasises acceptance/commissioning, ongoing QA, formal control after servicing or modification, and learning from actual or potential misadministration.
- Its sample tests, frequencies and tolerances are guidance; they must not be silently converted into universal or THHS-specific requirements.
4. Summary
4.1. 1–3 — Introduction, justification and responsibilities
- Defines scope and justification, then allocates complementary responsibilities across management, clinicians, therapists, physicists, the RSO, suppliers and service personnel.
- Section 3.6 describes the RSO's advisory and oversight role and states that delegation does not remove the Responsible Person's legal responsibility. Annex B lists illustrative RSO duties, including monitoring, training, review and reporting; Queensland law determines the local appointment.
4.2. 4 — Optimisation of protection
- Addresses facility and equipment design and operation, source/equipment calibration, clinical dosimetry and QA as an integrated system.
- Section 4.2 invokes multiple safeguards (defence in depth) for critical radiotherapy components.
4.3. 5 — Pregnancy
- Recommends processes to identify and manage possible pregnancy and to assess fetal exposure where clinically relevant.
4.4. 6 — Quality assurance
- Covers clinical and technical QA, documented responsibilities, checks, review and corrective action.
4.5. 7 — Accidents and incidents
- Addresses prevention, immediate control, assessment, investigation, reporting and learning from actual or potential unintended exposure.
4.6. 8 — Treatment planning and delivery
- Covers prescription, patient identification, planning, verification, independent checks, data integrity and accurate delivery.
4.7. 9–10 — Brachytherapy source care and death with a source in situ
- Provides source-control principles for brachytherapy and special arrangements when radioactive material remains in a deceased patient.
4.8. 11–14 — Occupational protection, sites, training and security
- Addresses staff protection, facility requirements, competence, source security, storage and transport.
- Section 12.1 discusses shielding specifications and survey of a completed room; it provides technical context for, rather than proof of, Queensland premises compliance.
4.9. Annexes
- Provide example content for a radiation management plan; RSO functions; equipment and commissioning records; calibration, servicing and QA; error/incident handling; source care; wipe tests; signs; and monitoring instruments.
- Annex B includes measurements and investigations following radiation-safety concerns among illustrative RSO duties; local action thresholds still need their own source.
- Annex L was removed in January 2015; use current instruments for dose limits.
5. Important definitions, roles, limits and records
- ROMP
- The radiation oncology medical physicist responsible for specialist calibration, dosimetry, commissioning, QA and technical safety functions within competence.
- Radiation oncologist
- Holds clinical responsibility for justification, prescription and clinical oversight.
- Radiation therapist
- Performs planning and/or delivery functions within authorisation and competence.
- Tolerance or action level
- A programme-specific technical control; guide examples require local validation and approval.
- Records
- Prescription, patient identification, commissioning, calibration, independent checks, QA, service/change release, training, source inventory and incidents.
6. Practical relationship to the THHS RSPP
- Closely supports the RSPP's local controls for commissioning, independent output verification, plan/MU checks, OIMS/data integrity, QA, maintenance release, brachytherapy and incident learning.
- For room design, use its shielding and site advice as national guidance. Assess the actual premises against the current Queensland statutory premises standard and the site's design and certificate records.
- Useful for explaining why multiple barriers and multidisciplinary checks are needed across the treatment pathway.
- Local controlled procedures and current professional standards should determine exact test methods, frequencies and tolerances.